MATINAS BIOPHARMA HOLDINGS, INC. Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • April 28th, 2017 • Matinas BioPharma Holdings, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 28th, 2017 Company Industry JurisdictionMatinas BioPharma Holdings, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
LEASE AGREEMENT CIP II/AR BRIDGEWATER HOLDINGS LLC (LANDLORD) toLease Agreement • April 28th, 2017 • Matinas BioPharma Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledApril 28th, 2017 Company IndustryTHIS LEASE, made and entered into this 15th day of December 2016, (the “Effective Date”) by and between CIP II/AR BRIDGEWATER HOLDINGS LLC, a Delaware limited liability company, having an office at c/o Advance Realty Development, 1041 U.S. Highway 202/206, Bridgewater, NJ 08807 (the "Landlord"), and MATINAS BIOPHARMA HOLDINGS, INC., a Delaware corporation, having an office at 1545 U.S. Highway 206, Suite 302, Bedminster, New Jersey 07921, (the "Tenant").